PEPTINOV

Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-Francois Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinovs strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinovs high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinovs value proposition is built on its unique capability to develop anti-self proteins products in the current pharmaceutical markets. Peptinovs most advanced product targets IL-6, a central pro-inflammatory cytokine involved in the pathogenesis of several diseases. Peptinovs anti-IL-6 immunotherapy is now in pha...